These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28167616)

  • 21. Potential Applications of the National Institute of Mental Health's Research Domain Criteria (RDoC) to Clinical Psychiatric Practice: How RDoC Might Be Used in Assessment, Diagnostic Processes, Case Formulation, Treatment Planning, and Clinical Notes.
    Yager J; Feinstein RE
    J Clin Psychiatry; 2017 Apr; 78(4):423-432. PubMed ID: 28002661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
    Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
    J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A behavioral defect of temporal association memory in mice that partly lack dopamine reuptake transporter.
    Deng S; Zhang L; Zhu T; Liu YM; Zhang H; Shen Y; Li WG; Li F
    Sci Rep; 2015 Dec; 5():17461. PubMed ID: 26658842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies.
    Costa A; Riedel M; Müller U; Möller HJ; Ettinger U
    Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression.
    Tilley MR; Cagniard B; Zhuang X; Han DD; Tiao N; Gu HH
    BMC Neurosci; 2007 Jun; 8():42. PubMed ID: 17584943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altering the development of the dopaminergic system through social play in rats: Implications for anxiety, depression, hyperactivity, and compulsivity.
    Parvopassu A; Oggiano M; Festucci F; Curcio G; Alleva E; Adriani W
    Neurosci Lett; 2021 Aug; 760():136090. PubMed ID: 34197903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inbred Lewis and Fischer 344 rat strains differ not only in novelty- and amphetamine-induced behaviors, but also in dopamine transporter activity in vivo.
    Gulley JM; Everett CV; Zahniser NR
    Brain Res; 2007 Jun; 1151():32-45. PubMed ID: 17395161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate.
    Calipari ES; Ferris MJ; Siciliano CA; Jones SR
    ACS Chem Neurosci; 2015 Jan; 6(1):155-62. PubMed ID: 25474655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic exposure to ethanol of male mice before mating produces attention deficit hyperactivity disorder-like phenotype along with epigenetic dysregulation of dopamine transporter expression in mouse offspring.
    Kim P; Choi CS; Park JH; Joo SH; Kim SY; Ko HM; Kim KC; Jeon SJ; Park SH; Han SH; Ryu JH; Cheong JH; Han JY; Ko KN; Shin CY
    J Neurosci Res; 2014 May; 92(5):658-70. PubMed ID: 24510599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A murine model of hyperdopaminergic state displays altered respiratory control.
    Vincent SG; Waddell AE; Caron MG; Walker JK; Fisher JT
    FASEB J; 2007 May; 21(7):1463-71. PubMed ID: 17255472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of the influence of a high-fat/high-carbohydrate diet on the level of anxiety and neuromotor and cognitive functions in Wistar and DAT-KO rats.
    Apryatin SA; Shipelin VA; Trusov NV; Mzhelskaya KV; Evstratova VS; Kirbaeva NV; Soto JS; Fesenko ZS; Gainetdinov RR; Gmoshinski IV
    Physiol Rep; 2019 Feb; 7(4):e13987. PubMed ID: 30784211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of genes on "positive valence systems" constructs: A systematic review.
    Hess JL; Kawaguchi DM; Wagner KE; Faraone SV; Glatt SJ
    Am J Med Genet B Neuropsychiatr Genet; 2016 Jan; 171B(1):92-110. PubMed ID: 26365619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the Research Domain Criteria (RDoC) framework to eating disorders: emerging concepts and research.
    Wildes JE; Marcus MD
    Curr Psychiatry Rep; 2015 May; 17(5):30. PubMed ID: 25773226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rats overexpressing the dopamine transporter display behavioral and neurobiological abnormalities with relevance to repetitive disorders.
    Hadar R; Edemann-Callesen H; Reinel C; Wieske F; Voget M; Popova E; Sohr R; Avchalumov Y; Priller J; van Riesen C; Puls I; Bader M; Winter C
    Sci Rep; 2016 Dec; 6():39145. PubMed ID: 27974817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Behavioral and pharmacological characteristics of mice lacking the dopamine transporter].
    Biala G
    Postepy Hig Med Dosw (Online); 2004; 58():560-4. PubMed ID: 15765018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's.
    Berridge KC; Aldridge JW; Houchard KR; Zhuang X
    BMC Biol; 2005 Feb; 3():4. PubMed ID: 15710042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cis-acting elements responsible for dopaminergic neuron-specific expression of zebrafish slc6a3 (dopamine transporter) in vivo are located remote from the transcriptional start site.
    Bai Q; Burton EA
    Neuroscience; 2009 Dec; 164(3):1138-51. PubMed ID: 19755139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.
    Gainetdinov RR; Mohn AR; Bohn LM; Caron MG
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11047-54. PubMed ID: 11572967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine transporter mutant mice in experimental neuropharmacology.
    Gainetdinov RR
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):301-13. PubMed ID: 18057916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.